Does the Drug Shortage White Paper Fall Short?
FDA Law Blog: Biosimilars
APRIL 8, 2024
pharmacy benefit managers (PBMs), group purchasing organizations (GPOs), wholesale distributors) play before a finished product ever makes it to a patient. For example, DEA and FDA jointly acknowledged in an August 1, 2023 letter that there have been ongoing shortages of various stimulant medications (e.g., Section I.C
Let's personalize your content